메뉴 건너뛰기




Volumn 195, Issue 1, 2010, Pages 54-66

The role of functional imaging in colorectal cancer

Author keywords

Colorectal cancer; Diffusion weighted imaging; Functional imaging; PET; Tumor perfusion

Indexed keywords

GLUCOSE; IRON OXIDE;

EID: 77954697898     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4422     Document Type: Review
Times cited : (56)

References (83)
  • 1
    • 0037340550 scopus 로고    scopus 로고
    • Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging
    • Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90:355-364
    • (2003) Br J Surg , vol.90 , pp. 355-364
    • Brown, G.1    Radcliffe, A.G.2    Newcombe, R.G.3    Dallimore, N.S.4    Bourne, M.W.5    Williams, G.T.6
  • 2
    • 34548165833 scopus 로고    scopus 로고
    • Functional imaging of cancer with emphasis on molecular techniques
    • Torigian DA, Huang SS, Houseni M, Alavi A. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin 2007; 57:206-224
    • (2007) CA Cancer J Clin , vol.57 , pp. 206-224
    • Torigian, D.A.1    Huang, S.S.2    Houseni, M.3    Alavi, A.4
  • 3
    • 33746434957 scopus 로고    scopus 로고
    • Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques
    • Alonzi R, Hoskin P. Functional imaging in clinical oncology: magnetic resonance imaging- and computerised tomography-based techniques. Clin Oncol (R Coll Radiol) 2006; 18:555-570
    • (2006) Clin Oncol (R Coll Radiol) , vol.18 , pp. 555-570
    • Alonzi, R.1    Hoskin, P.2
  • 4
    • 58649102074 scopus 로고    scopus 로고
    • Established, emerging and future roles of PET/CT in the management of colorectal cancer
    • Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM. Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 2009; 64:225-237
    • (2009) Clin Radiol , vol.64 , pp. 225-237
    • Herbertson, R.A.1    Scarsbrook, A.F.2    Lee, S.T.3    Tebbutt, N.4    Scott, A.M.5
  • 5
    • 68149129637 scopus 로고    scopus 로고
    • Functional imaging of colorectal cancer: Positron emission tomography, magnetic resonance imaging, and computed tomography
    • Kapse N, Goh V. Functional imaging of colorectal cancer: positron emission tomography, magnetic resonance imaging, and computed tomography. Clin Colorectal Cancer 2009; 8:77-87
    • (2009) Clin Colorectal Cancer , vol.8 , pp. 77-87
    • Kapse, N.1    Goh, V.2
  • 6
    • 33847173683 scopus 로고    scopus 로고
    • Functional imaging of colorectal cancer angiogenesis
    • DOI 10.1016/S1470-2045(07)70075-X, PII S147020450770075X
    • Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 2007; 8:245-255 (Pubitemid 46291714)
    • (2007) Lancet Oncology , vol.8 , Issue.3 , pp. 245-255
    • Goh, V.1    Padhani, A.R.2    Rasheed, S.3
  • 7
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70
    • (2000) Cell , vol.100 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 8
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50[suppl 1]:122S-150S
    • (2009) J Nucl Med , vol.50 , Issue.SUPPL. 1
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 9
    • 33751011346 scopus 로고    scopus 로고
    • Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma
    • Park IJ, Kim HC, Yu CS, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 2006; 32:941-947
    • (2006) Eur J Surg Oncol , vol.32 , pp. 941-947
    • Park, I.J.1    Kim, H.C.2    Yu, C.S.3
  • 10
    • 33644628349 scopus 로고    scopus 로고
    • Gastrointestinal tract malignancies and positron emission tomography: An overview
    • Esteves FP, Schuster DM, Halkar RK. Gastrointestinal tract malignancies and positron emission tomography: an overview. Semin Nucl Med 2006; 36:169-181
    • (2006) Semin Nucl Med , vol.36 , pp. 169-181
    • Esteves, F.P.1    Schuster, D.M.2    Halkar, R.K.3
  • 12
    • 34748814336 scopus 로고    scopus 로고
    • Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemoradiation therapy
    • Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging 2007; 34:1583-1593
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 1583-1593
    • Capirci, C.1    Rampin, L.2    Erba, P.A.3
  • 13
    • 33748115129 scopus 로고    scopus 로고
    • 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery
    • 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006; 47:14-22
    • (2006) J Nucl Med , vol.47 , pp. 14-22
    • Kalff, V.1    Duong, C.2    Drummond, E.G.3    Matthews, J.P.4    Hicks, R.J.5
  • 14
    • 34848858976 scopus 로고    scopus 로고
    • (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer
    • Chen LB, Tong JL, Song HZ, Zhu H, Wang YC. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007; 13:5025-5029
    • (2007) World J Gastroenterol , vol.13 , pp. 5025-5029
    • Chen, L.B.1    Tong, J.L.2    Song, H.Z.3    Zhu, H.4    Wang, Y.C.5
  • 15
    • 40949110505 scopus 로고    scopus 로고
    • FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer
    • Bassi MC, Turri L, Sacchetti G, et al. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 2008; 70:1423-1426
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 1423-1426
    • Bassi, M.C.1    Turri, L.2    Sacchetti, G.3
  • 16
    • 0033925753 scopus 로고    scopus 로고
    • A meta- analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer
    • Huebner RH, Park KC, Shepherd JE, et al. A meta- analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41:1177-1189
    • (2000) J Nucl Med , vol.41 , pp. 1177-1189
    • Huebner, R.H.1    Park, K.C.2    Shepherd, J.E.3
  • 17
    • 61349123591 scopus 로고    scopus 로고
    • Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations
    • Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11:102-125
    • (2009) Neoplasia , vol.11 , pp. 102-125
    • Padhani, A.R.1    Liu, G.2    Koh, D.M.3
  • 18
    • 41849147484 scopus 로고    scopus 로고
    • Technology insight: Water diffusion MRI - A potential new biomarker of response to cancer therapy
    • Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008; 5:220-233
    • (2008) Nat Clin Pract Oncol , vol.5 , pp. 220-233
    • Patterson, D.M.1    Padhani, A.R.2    Collins, D.J.3
  • 19
    • 33747141496 scopus 로고    scopus 로고
    • High-b-value diffusion weighted MRI in colorectal cancer
    • Ichikawa T, Erturk SM, Motosugi U, et al. High-b-value diffusion weighted MRI in colorectal cancer. AJR 2006; 187:181-184
    • (2006) AJR , vol.187 , pp. 181-184
    • Ichikawa, T.1    Erturk, S.M.2    Motosugi, U.3
  • 20
    • 75349104448 scopus 로고    scopus 로고
    • Diffusion-weighted MR imaging of the liver
    • Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010; 254:47-66
    • (2010) Radiology , vol.254 , pp. 47-66
    • Taouli, B.1    Koh, D.M.2
  • 21
    • 52049122344 scopus 로고    scopus 로고
    • Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination
    • Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 2008; 18:903-910
    • (2008) Eur Radiol , vol.18 , pp. 903-910
    • Koh, D.M.1    Brown, G.2    Riddell, A.M.3
  • 22
    • 39049083433 scopus 로고    scopus 로고
    • Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique
    • Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18:477-485
    • (2008) Eur Radiol , vol.18 , pp. 477-485
    • Bruegel, M.1    Holzapfel, K.2    Gaa, J.3
  • 23
    • 60549088306 scopus 로고    scopus 로고
    • Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro- 2-deoxy-d-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases
    • Ono K, Ochiai R, Yoshida T, et al. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro- 2-deoxy-d-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. J Magn Reson Imaging 2009; 29:336-340
    • (2009) J Magn Reson Imaging , vol.29 , pp. 336-340
    • Ono, K.1    Ochiai, R.2    Yoshida, T.3
  • 24
    • 0346037048 scopus 로고    scopus 로고
    • Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: Preliminary results of a prospective study
    • DOI 10.1016/S0720-048X(02)00231-0, PII S0720048X02002310
    • Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003; 45:214-222 (Pubitemid 36197717)
    • (2003) European Journal of Radiology , vol.45 , Issue.3 , pp. 214-222
    • Hein, P.A.1    Kremser, C.2    Judmaier, W.3    Griebel, J.4    Pfeiffer, K.-P.5    Kreczy, A.6    Hug, E.B.7    Lukas, P.8    Devries, A.F.9
  • 25
    • 51549112352 scopus 로고    scopus 로고
    • Apparent diffusion coefficient: Potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases
    • Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248:894-900
    • (2008) Radiology , vol.248 , pp. 894-900
    • Cui, Y.1    Zhang, X.P.2    Sun, Y.S.3    Tang, L.4    Shen, L.5
  • 26
    • 0037183247 scopus 로고    scopus 로고
    • Diffusion MRI for prediction of response of rectal cancer to chemoradiation
    • DOI 10.1016/S0140-6736(02)09520-X
    • Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360:307-308 (Pubitemid 34874724)
    • (2002) Lancet , vol.360 , Issue.9329 , pp. 307-308
    • Dzik-Jurasz, A.1    Domenig, C.2    George, M.3    Wolber, J.4    Padhani, A.5    Brown, G.6    Doran, S.7
  • 27
    • 0038386614 scopus 로고    scopus 로고
    • Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma
    • DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56:958-965
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 958-965
    • DeVries, A.F.1    Kremser, C.2    Hein, P.A.3
  • 28
    • 33947654364 scopus 로고    scopus 로고
    • Predicting response of colorectal hepatic metastasis: Value of pretreatment apparent diffusion coefficients
    • Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR 2007; 188:1001-1008
    • (2007) AJR , vol.188 , pp. 1001-1008
    • Koh, D.M.1    Scurr, E.2    Collins, D.3
  • 29
    • 51449114255 scopus 로고    scopus 로고
    • Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: Early experience
    • Kim JK, Kim KA, Park BW, Kim N, Cho KS. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 2008; 28:714-719
    • (2008) J Magn Reson Imaging , vol.28 , pp. 714-719
    • Kim, J.K.1    Kim, K.A.2    Park, B.W.3    Kim, N.4    Cho, K.S.5
  • 31
    • 75349101061 scopus 로고    scopus 로고
    • Lymphatic metastases from pelvic tumors: Anatomic classifi- Cation, characterization, and staging
    • McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic classifi- cation, characterization, and staging. Radiology 2010; 254:31-46
    • (2010) Radiology , vol.254 , pp. 31-46
    • McMahon, C.J.1    Rofsky, N.M.2    Pedrosa, I.3
  • 32
    • 0028270499 scopus 로고
    • Prognostic profile in rectal cancer
    • Herrera L, Brown MT. Prognostic profile in rectal cancer. Dis Colon Rectum 1994; 37[2 suppl]:S1-S5
    • (1994) Dis Colon Rectum , vol.37 , Issue.2 SUPPL.
    • Herrera, L.1    Brown, M.T.2
  • 33
    • 0027136775 scopus 로고
    • The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer
    • Kotanagi H, Fukuoka T, Shibata Y, et al. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. J Surg Oncol 1993; 54:252-254
    • (1993) J Surg Oncol , vol.54 , pp. 252-254
    • Kotanagi, H.1    Fukuoka, T.2    Shibata, Y.3
  • 34
    • 4544382535 scopus 로고    scopus 로고
    • High-resolution MR imaging for nodal staging in rectal cancer: Are there any criteria in addition to the size?
    • Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004; 52:78-83
    • (2004) Eur J Radiol , vol.52 , pp. 78-83
    • Kim, J.H.1    Beets, G.L.2    Kim, M.J.3    Kessels, A.G.4    Beets-Tan, R.G.5
  • 35
    • 29744471157 scopus 로고    scopus 로고
    • Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: A meta-analysis
    • Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006; 7:52-60
    • (2006) Lancet Oncol , vol.7 , pp. 52-60
    • Will, O.1    Purkayastha, S.2    Chan, C.3
  • 37
    • 60249092434 scopus 로고    scopus 로고
    • Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients
    • Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55:761-769
    • (2009) Eur Urol , vol.55 , pp. 761-769
    • Thoeny, H.C.1    Triantafyllou, M.2    Birkhaeuser, F.D.3
  • 38
    • 0037134709 scopus 로고    scopus 로고
    • Clinical application of antiangiogenic therapy: Microvessel density, what it does and doen't tell us
    • Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94:883-893 (Pubitemid 34778087)
    • (2002) Journal of the National Cancer Institute , vol.94 , Issue.12 , pp. 883-893
    • Hlatky, L.1    Hahnfeldt, P.2    Folkman, J.3
  • 39
  • 41
    • 33645413642 scopus 로고    scopus 로고
    • Imaging tumor angiogenesis: Functional assessment using MDCT or MRI?
    • Goh V, Padhani AR. Imaging tumor angiogenesis: functional assessment using MDCT or MRI? Abdom Imaging 2006; 31:194-199
    • (2006) Abdom Imaging , vol.31 , pp. 194-199
    • Goh, V.1    Padhani, A.R.2
  • 42
    • 58949094890 scopus 로고    scopus 로고
    • Body perfusion CT: Technique, clinical applications, and advances
    • Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am 2009; 47:161-178
    • (2009) Radiol Clin North Am , vol.47 , pp. 161-178
    • Kambadakone, A.R.1    Sahani, D.V.2
  • 43
    • 13844280371 scopus 로고    scopus 로고
    • Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations
    • Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005; 234:785-792
    • (2005) Radiology , vol.234 , pp. 785-792
    • Sahani, D.V.1    Kalva, S.P.2    Hamberg, L.M.3
  • 44
    • 77955850517 scopus 로고    scopus 로고
    • Evaluation of angiogenesis in colorectal carcinoma with multidetector- Row CT multislice perfusion imaging
    • Epub 2009 May 27
    • Feng ST, Sun CH, Li ZP, et al. Evaluation of angiogenesis in colorectal carcinoma with multidetector- row CT multislice perfusion imaging. Eur J Radiol [Epub 2009 May 27]
    • Eur J Radiol
    • Feng, S.T.1    Sun, C.H.2    Li, Z.P.3
  • 45
    • 24644515509 scopus 로고    scopus 로고
    • Quantitative assessment of colorectal cancer perfusion using MDCT: Inter- And intraobserver agreement
    • Goh V, Halligan S, Hugill JA, Bassett P, Bartram CI. Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement. AJR 2005; 185:225-231
    • (2005) AJR , vol.185 , pp. 225-231
    • Goh, V.1    Halligan, S.2    Hugill, J.A.3    Bassett, P.4    Bartram, C.I.5
  • 46
    • 33846512886 scopus 로고    scopus 로고
    • Differentiation between diverticulitis and colorectal cancer: Quantitative CT perfusion measurements versus morphologic criteria - Initial experience
    • Goh V, Halligan S, Taylor SA, Burling D, Bassett P, Bartram CI. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria - initial experience. Radiology 2007; 242:456-462
    • (2007) Radiology , vol.242 , pp. 456-462
    • Goh, V.1    Halligan, S.2    Taylor, S.A.3    Burling, D.4    Bassett, P.5    Bartram, C.I.6
  • 47
    • 0030698625 scopus 로고    scopus 로고
    • Colorectal cancer: Diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols
    • Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997; 205:716-720
    • (1997) Radiology , vol.205 , pp. 716-720
    • Leggett, D.A.1    Kelley, B.B.2    Bunce, I.H.3    Miles, K.A.4
  • 48
    • 59249106620 scopus 로고    scopus 로고
    • Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study
    • Goh V, Halligan S, Wellsted DM, Bartram CI. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol 2009; 19:79-89
    • (2009) Eur Radiol , vol.19 , pp. 79-89
    • Goh, V.1    Halligan, S.2    Wellsted, D.M.3    Bartram, C.I.4
  • 49
    • 70249123482 scopus 로고    scopus 로고
    • Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer
    • Hayano K, Shuto K, Koda K, Yanagawa N, Okazumi S, Matsubara H. Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis Colon Rectum 2009; 52:1624-1629
    • (2009) Dis Colon Rectum , vol.52 , pp. 1624-1629
    • Hayano, K.1    Shuto, K.2    Koda, K.3    Yanagawa, N.4    Okazumi, S.5    Matsubara, H.6
  • 50
    • 34447498780 scopus 로고    scopus 로고
    • CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: Initial experience
    • Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 2007; 244:486-493
    • (2007) Radiology , vol.244 , pp. 486-493
    • Bellomi, M.1    Petralia, G.2    Sonzogni, A.3    Zampino, M.G.4    Rocca, A.5
  • 51
    • 33745963117 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
    • DOI 10.1200/JCO.2006.06.8080
    • Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006; 24:3293-3298 (Pubitemid 46622069)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.20 , pp. 3293-3298
    • Hylton, N.1
  • 52
    • 46949084994 scopus 로고    scopus 로고
    • Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: Tools or decorations?
    • Sessa C, Guibal A, Del Conte G, Rüegg C. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? Nat Clin Pract Oncol 2008; 5:378-391
    • (2008) Nat Clin Pract Oncol , vol.5 , pp. 378-391
    • Sessa, C.1    Guibal, A.2    Del Conte, G.3    Rüegg, C.4
  • 53
    • 33747039809 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis
    • Atkin G, Taylor NJ, Daley FM, et al. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surg 2006; 93:992-1000
    • (2006) Br J Surg , vol.93 , pp. 992-1000
    • Atkin, G.1    Taylor, N.J.2    Daley, F.M.3
  • 54
    • 1642303272 scopus 로고    scopus 로고
    • Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas
    • Tuncbilek N, Karakas HM, Altaner S. Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas. Abdom Imaging 2004; 29:166-172
    • (2004) Abdom Imaging , vol.29 , pp. 166-172
    • Tuncbilek, N.1    Karakas, H.M.2    Altaner, S.3
  • 55
    • 1842615866 scopus 로고    scopus 로고
    • Perfusion MR imaging of extracranial tumor angiogenesis
    • Padhani AR, Dzik-Jurasz A. Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 2004; 15:41-57
    • (2004) Top Magn Reson Imaging , vol.15 , pp. 41-57
    • Padhani, A.R.1    Dzik-Jurasz, A.2
  • 56
    • 51449121001 scopus 로고    scopus 로고
    • Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer
    • Eby PR, Partridge SC, White SW, et al. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Acad Radiol 2008; 15:1246-1254
    • (2008) Acad Radiol , vol.15 , pp. 1246-1254
    • Eby, P.R.1    Partridge, S.C.2    White, S.W.3
  • 57
    • 34047102909 scopus 로고    scopus 로고
    • Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors
    • Lankester KJ, Taylor JN, Stirling JJ, et al. Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 2007; 25:796-805
    • (2007) J Magn Reson Imaging , vol.25 , pp. 796-805
    • Lankester, K.J.1    Taylor, J.N.2    Stirling, J.J.3
  • 58
    • 34249864501 scopus 로고    scopus 로고
    • Measuring tumor perfusion in control and treated murine tumors: Correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography
    • Niermann KJ, Fleischer AC, Huamani J, et al. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med 2007; 26:749-756
    • (2007) J Ultrasound Med , vol.26 , pp. 749-756
    • Niermann, K.J.1    Fleischer, A.C.2    Huamani, J.3
  • 59
    • 0347615101 scopus 로고    scopus 로고
    • Dynamic contrast enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: RESULTS from two phase I studies
    • Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: RESULTS from two phase I studies. J Clin Oncol 2003; 21:3955-3964
    • (2003) J Clin Oncol , vol.21 , pp. 3955-3964
    • Morgan, B.1    Thomas, A.L.2    Drevs, J.3
  • 60
    • 0035205433 scopus 로고    scopus 로고
    • Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
    • George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88:1628-1636
    • (2001) Br J Surg , vol.88 , pp. 1628-1636
    • George, M.L.1    Dzik-Jurasz, A.S.2    Padhani, A.R.3
  • 62
    • 0034905902 scopus 로고    scopus 로고
    • BOLD MRI of human tumor oxygenation during carbogen breathing
    • Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 2001; 14:156-163
    • (2001) J Magn Reson Imaging , vol.14 , pp. 156-163
    • Taylor, N.J.1    Baddeley, H.2    Goodchild, K.A.3
  • 63
    • 70449698809 scopus 로고    scopus 로고
    • Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: A potential novel biomarker of oxygenation changes in solid tumors
    • O'Connor JP, Naish JH, Parker GJ, et al. Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. Int J Radiat Oncol Biol Phys 2009; 75:1209-1215
    • (2009) Int J Radiat Oncol Biol Phys , vol.75 , pp. 1209-1215
    • O'Connor, J.P.1    Naish, J.H.2    Parker, G.J.3
  • 65
    • 51049123629 scopus 로고    scopus 로고
    • Biological image guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG?
    • Roels S, Slagmolen P, Nuyts J, et al. Biological image guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Acta Oncol 2008; 47:1237-1248
    • (2008) Acta Oncol , vol.47 , pp. 1237-1248
    • Roels, S.1    Slagmolen, P.2    Nuyts, J.3
  • 66
    • 54949157918 scopus 로고    scopus 로고
    • Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study
    • Dietz DW, Dehdashti F, Grigsby PW, et al. Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Dis Colon Rectum 2008; 51:1641-1648
    • (2008) Dis Colon Rectum , vol.51 , pp. 1641-1648
    • Dietz, D.W.1    Dehdashti, F.2    Grigsby, P.W.3
  • 67
    • 0242298198 scopus 로고    scopus 로고
    • In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
    • Francis DL, Freeman A, Visvikis D, et al. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut 2003; 52:1602-1606
    • (2003) Gut , vol.52 , pp. 1602-1606
    • Francis, D.L.1    Freeman, A.2    Visvikis, D.3
  • 68
    • 66749108083 scopus 로고    scopus 로고
    • Diffusion-weighted imaging of prostate cancer: Correlation between apparent diffusion coefficient values and tumor proliferation
    • Wang XZ, Wang B, Gao ZQ, et al. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 2009; 29:1360-1366
    • (2009) J Magn Reson Imaging , vol.29 , pp. 1360-1366
    • Wang, X.Z.1    Wang, B.2    Gao, Z.Q.3
  • 71
    • 16844381500 scopus 로고    scopus 로고
    • Imaging apoptosis in vivo using 124I-annexin V and PET
    • Keen HG, Dekker BA, Disley L, et al. Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 2005; 32:395-402
    • (2005) Nucl Med Biol , vol.32 , pp. 395-402
    • Keen, H.G.1    Dekker, B.A.2    Disley, L.3
  • 72
    • 77954746612 scopus 로고    scopus 로고
    • Multifunctional MR imaging assessment: A look into the future
    • Koh DM, Thoeny HC, eds. Berlin, Germany: Spinger
    • Padhani AR. Multifunctional MR imaging assessment: a look into the future. In: Koh DM, Thoeny HC, eds. Diffusion-weighted MR imaging. Berlin, Germany: Spinger, 2010:165-180
    • (2010) Diffusion-weighted MR Imaging , pp. 165-180
    • Padhani, A.R.1
  • 73
    • 30944452436 scopus 로고    scopus 로고
    • Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients
    • Willett CG, Boucher Y, Duda DG, et al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 2005; 23:8136-8139
    • (2005) J Clin Oncol , vol.23 , pp. 8136-8139
    • Willett, C.G.1    Boucher, Y.2    Duda, D.G.3
  • 74
    • 46849095454 scopus 로고    scopus 로고
    • Quantification of viable tumor microvascular characteristics by multispectral analysis
    • Berry LR, Barck KH, Go MA, et al. Quantification of viable tumor microvascular characteristics by multispectral analysis. Magn Reson Med 2008; 60:64-72
    • (2008) Magn Reson Med , vol.60 , pp. 64-72
    • Berry, L.R.1    Barck, K.H.2    Go, M.A.3
  • 75
    • 61749090699 scopus 로고    scopus 로고
    • Unresectable hepatocellular carcinoma: Serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging
    • Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009; 250:466-473
    • (2009) Radiology , vol.250 , pp. 466-473
    • Kamel, I.R.1    Liapi, E.2    Reyes, D.K.3    Zahurak, M.4    Bluemke, D.A.5    Geschwind, J.F.6
  • 76
    • 74749085829 scopus 로고    scopus 로고
    • Current progress in targeted therapy for colorectal cancer
    • Ortega J, Vigil CE, Chodkiewicz C. Current progress in targeted therapy for colorectal cancer. Cancer Control 2010; 17:7-15
    • (2010) Cancer Control , vol.17 , pp. 7-15
    • Ortega, J.1    Vigil, C.E.2    Chodkiewicz, C.3
  • 77
    • 70349939382 scopus 로고    scopus 로고
    • Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
    • Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 2009; 101:1308-1324
    • (2009) J Natl Cancer Inst , vol.101 , pp. 1308-1324
    • Siena, S.1    Sartore-Bianchi, A.2    Di Nicolantonio, F.3    Balfour, J.4    Bardelli, A.5
  • 78
    • 67650380136 scopus 로고    scopus 로고
    • Biomarkers of response and resistance to antiangiogenic therapy
    • Jain RK, Duda DG, Willett CG, et al. Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol 2009; 6:327-338
    • (2009) Nat Rev Clin Oncol , vol.6 , pp. 327-338
    • Jain, R.K.1    Duda, D.G.2    Willett, C.G.3
  • 80
    • 11144354392 scopus 로고    scopus 로고
    • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
    • Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10:145-147
    • (2004) Nat Med , vol.10 , pp. 145-147
    • Willett, C.G.1    Boucher, Y.2    Di Tomaso, E.3
  • 81
    • 58149352912 scopus 로고    scopus 로고
    • Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer
    • Manning HC, Merchant NB, Foutch AC, et al. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res 2008; 14:7413-7422
    • (2008) Clin Cancer Res , vol.14 , pp. 7413-7422
    • Manning, H.C.1    Merchant, N.B.2    Foutch, A.C.3
  • 82
    • 33746548452 scopus 로고    scopus 로고
    • Predicting benefit from anti-angiogenic agents in malignancy
    • Jubb AM, Oates AJ, Holden S, Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer 2006; 6:626-635
    • (2006) Nat Rev Cancer , vol.6 , pp. 626-635
    • Jubb, A.M.1    Oates, A.J.2    Holden, S.3    Koeppen, H.4
  • 83
    • 47849090992 scopus 로고    scopus 로고
    • Quantitative imaging biomarkers in the clinical development of targeted therapeutics: Current and future perspectives
    • O'Connor JP, Jackson A, Asselin MC, Buckley DL, Parker GJ, Jayson GC. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. Lancet Oncol 2008; 9:766-776
    • (2008) Lancet Oncol , vol.9 , pp. 766-776
    • O'Connor, J.P.1    Jackson, A.2    Asselin, M.C.3    Buckley, D.L.4    Parker, G.J.5    Jayson, G.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.